Structure and Content of a Taxonomy to Support the Use of Real-World Evidence by Health Technology Assessment Practitioners and Healthcare Decision Makers-Reference-Cited by-同舟云学术

Structure and Content of a Taxonomy to Support the Use of Real-World Evidence by Health Technology Assessment Practitioners and Healthcare Decision Makers

Published:2023-04 Issue:4 Volume:26 Page:20-31
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Murphy Linda A.,Akehurst Ron,Solà-Morales Oriol,Cunningham David,Mestre-Ferrandiz Jorge,Franklin Matthew,de Pouvourville Gérard

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference26 articles.

1. Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance;Jaksa;J Comp Eff Res,2021

2. Using real-world data in the health technology assessment of pharmaceuticals: strengths, difficulties and a pragmatic way forward;Akehurst;Value Health,2023

3. The real-world evidence workstream in EUreccA 2025: how the task was addressed;Murphy;Value Health,2023

4. Across-country variations of real-world data and evidence for drugs: a 5-European-country study;de Pouvourville;Value Health,2023

5. Data governance for real-world data management: a proposal for a checklist for support decision making;Solà-Morales;Value Health,2023

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force;Value in Health;2024-06

2. Across-Country Variations of Real-World Data and Evidence for Drugs: A 5-European-Country Study;Value in Health;2023-04

3. EUreccA 2025: A Multistakeholder Effort to Further Real-World Evidence in Healthcare Decision Making;Value in Health;2023-04

4. The Real-World Evidence Workstream in EUreccA 2025: How the Task Was Addressed;Value in Health;2023-04

5. Using Real-World Data in the Health Technology Assessment of Pharmaceuticals: Strengths, Difficulties, and a Pragmatic Way Forward;Value in Health;2023-04